Patent · US Active

Nucleic acid constructs

US8663657B2 · kind B2 · utility

0Cited by
8References
25Claims
0Family size

Assignee

Inventor

Key dates

Filing dateOct 11, 2004
Grant dateMar 4, 2014
Priority date
Expiry dateApr 3, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2830/60
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A nucleic acid construct comprising a chimeric promoter sequence and a cloning site for insertion of a coding sequence in operable linkage with the chimeric promoter, wherein the chimeric promoter sequence comprises: (a) a hCMV immediate early promoter sequence; (b) exon 1 and at least a part of exon 2 of the hCMV major immediate early gene; and (c) a heterologous intron provided in place of the intron A region of the hCMV major immediate early gene.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.